| Symbol | ICCM |
|---|---|
| Name | ICECURE MEDICAL LTD. |
| Sector | HEALTH CARE |
| Region | Middle East |
| Industry | Medical/Dental Instruments |
| Address | 7 HAESHEL STREET,SOUTHERN INDUSTRIAL PARK, CAESAREA, 3079504, Israel |
| Telephone | +972 46230333 |
| Fax | — |
| — | |
| Website | https://www.icecure-medical.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001584371 |
| Description | Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications. Additional info from NASDAQ: |
IceCure Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
Read moreNew Form 424B5 - IceCure Medical Ltd. <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0001213900-26-055179 <b>Size:</b> 381 KB
Read moreIceCure Reports First Quarter 2026 Financial Results:ProSense® Sales Increase Substantially in the U.S. and North America
Read moreIceCure Medical to Report First Quarter 2026 Financial and Operating Results on May 12, 2026
Read moreIceCure Medical to Report First Quarter 2026 Financial and Operating Results on May 12, 2026
Read moreIceCure Showcases ProSense® Cryoablation at American Society of Breast Surgeons 2026 Annual Meeting as Commercial Momentum Accelerates in the U.S. Market
Read moreIceCure Participates in Society of Breast Imaging Symposium 2026 as U.S. ProSense® Revenue Increases by 30%+ in First Quarter of 2026 Compared to First Quarter of 2025
Read moreNew Form EFFECT - IceCure Medical Ltd. <b>Filed:</b> 2026-04-10 <b>AccNo:</b> 9999999995-26-001153 <b>Size:</b> 1 KB
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT06300125 | Percutaneous Cryoablation of Low-risk Early Breast Cancer | — | Breast Cancer | Recruiting | 2024-04-15 | 2031-03-01 | ClinicalTrials.gov |
| NCT02200705 | Cryoablation of Low Risk Small Breast Cancer- ICE3 Trial | Na | Breast Cancer | Completed | 2014-10-01 | 2024-05-26 | ClinicalTrials.gov |
| NCT02399124 | Post Marketing Surveillance for PROSENSE™ a Cryotherapy Treatment of Renal Cell… | Na | Renal Cell Carcinoma | Active_Not_Recruiting | 2014-07-01 | 2026-03-01 | ClinicalTrials.gov |
| NCT01735812 | Laparoscopic Cryoablation of Uterine Fibroids | Na | Symptomatic Uterine Fibroids | Withdrawn | 2012-12-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01671943 | Cryotherapy for Breast Cancer Trial | Na | Breast Carcinoma | Completed | 2012-08-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT00910312 | ICE-SENSE™ Cryotherapy for Breast Fibroadenoma Trial | Na | Fibroadenoma | Completed | 2009-04-01 | 2013-01-01 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Ice-Sense3TM | Other | Approved | Breast Carcinoma | COMPLETED | NCT01671943 |
| IceSense3 system | Other | Approved | Symptomatic Uterine Fibroids | WITHDRAWN | NCT01735812 |
| Ice-Sense3TM/ ProSenseTM | Other | Approved | Breast Cancer | COMPLETED | NCT02200705 |
| Cryoablation | Other | Preclinical | Breast Cancer | RECRUITING | NCT06300125 |
| PROSENSE™ | Other | Approved | Renal Cell Carcinoma | ACTIVE_NOT_RECRUITING | NCT02399124 |
| Cryoablation | PROCEDURE | Preclinical | Breast Cancer | RECRUITING | NCT06300125 |
| PROSENSE™ | DEVICE | Approved | Renal Cell Carcinoma | ACTIVE_NOT_RECRUITING | NCT02399124 |
| Ice-Sense3TM/ ProSenseTM | DEVICE | Approved | Breast Cancer | COMPLETED | NCT02200705 |
| IceSense3 system | DEVICE | Approved | Symptomatic Uterine Fibroids | WITHDRAWN | NCT01735812 |
| Ice-Sense3TM | DEVICE | Approved | Breast Carcinoma | COMPLETED | NCT01671943 |
| Ice-Sense | DEVICE | Approved | Fibroadenoma | COMPLETED | NCT00910312 |